Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-25 @ 9:22 PM
Study NCT ID:
NCT05997056
Status:
RECRUITING
Last Update Posted:
2024-07-16
First Post:
2023-08-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors
Sponsor:
Aadi Bioscience, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-07
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-08
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-10
First Submit QC Date:
None
Study First Post Date:
2023-08-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-15
Last Update Post Date:
2024-07-16
Last Update Post Date Type:
ACTUAL